Device Trial Radar · NCT06257628
MACE CDS Software Master Enrollment Protocol
Last checked: Nov 20, 2026Latest source record: Nov 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Sep 14, 2023
Primary completion
May 31, 2025
Study completion May 31, 2025
Sponsor
- Lead sponsor
- Beckman Coulter, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 14, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 23 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This protocol will collect real world EHR data to support the product development life cycle activities associated with developing the Major Adverse Cardiac Events (MACE) Clinical Decision Support (CDS) software. The data will also be utilized in subsequent clinical validation to support an FDA application and/or applications to other regulatory agencies as needed.
Conditions
- Cardiac Events
Interventions
Index EventDevice
Patients with at least one Beckman High Sensitivity Troponin test at the Emergency Department visit
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance Characteristics NPV (Negative Predictive Value), Specificity and SensitivityTime frame: Within 30-days from the Emergency Department Visit with suspicion of ACS (Acute Coronary Syndrome)
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Johns Hopkins University
Baltimore, Maryland
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.